Yingke Liang

1.6k total citations · 1 hit paper
29 papers, 1.1k citations indexed

About

Yingke Liang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yingke Liang has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Cancer Research and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yingke Liang's work include Cancer, Hypoxia, and Metabolism (8 papers), Cancer-related gene regulation (7 papers) and Prostate Cancer Treatment and Research (7 papers). Yingke Liang is often cited by papers focused on Cancer, Hypoxia, and Metabolism (8 papers), Cancer-related gene regulation (7 papers) and Prostate Cancer Treatment and Research (7 papers). Yingke Liang collaborates with scholars based in China, United States and Macao. Yingke Liang's co-authors include Yanqing Ding, Fuyao Song, Wenting Liao, Liang Li, Xiaoxia Zhu, Wei Wang, Yuhui Yan, Fangfang Wang, Zhao‐Chong Zeng and Wenjie Liao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and International Journal of Cancer.

In The Last Decade

Yingke Liang

29 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer

2019 588 citations Wei Wang, Xiao-Liang Lan et al. Molecular Cancer profile →

Peers

Yingke Liang

ONCOL

PRM

IMMUN

Junlu Wu China

Xueqi Ou China

Dongya Zhang China

Pierre‐Benoit Ancey France

Sida Qin China

Shanhua Tang China

Yanxia Lu China

Hailong Wang China

Lei Xi China

Bo Pang China

Junlu Wu China

Yingke Liang

809 ×1.1

640 ×1.2

220 ×0.9

ONCOL

103 ×0.7

PRM

250 ×2.0

IMMUN

Citations per year, relative to Yingke Liang Yingke Liang (= 1×) peers Junlu Wu

Countries citing papers authored by Yingke Liang

Since Specialization

Citations

This map shows the geographic impact of Yingke Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingke Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingke Liang more than expected).

Fields of papers citing papers by Yingke Liang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingke Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingke Liang. The network helps show where Yingke Liang may publish in the future.

Co-authorship network of co-authors of Yingke Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Yingke Liang. A scholar is included among the top collaborators of Yingke Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingke Liang. Yingke Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Yuting, Wenjie Xie, Xin Zhou, et al.. (2025). Precision targeted melanoma therapy via cuproptosis/chemodynamic and chemotherapy: An engineering MCHS-CuMOF nanodelivery system. Biomaterials Advances. 171. 214228–214228. 5 indexed citations

Huang, Yaqiang, Haiying Zhu, Qi Wang, et al.. (2025). Development and validation of a kinase-related gene signature as a novel diagnostic and prognostic model for prostate cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(4). 167722–167722. 2 indexed citations

Xie, Wenjie, Zhihao Zou, Yuting Zhang, et al.. (2024). Fluorescent Nanoparticles Achieve Efficient Photothermal Conversion and Enhanced Antitumor Efficacy Through Intermolecular Aggregation‐Caused Quenching. SHILAP Revista de lepidopterología. 6(3). 7 indexed citations

Liu, Ren, Zhihao Zou, Lingwu Chen, et al.. (2024). FKBP10 promotes clear cell renal cell carcinoma progression and regulates sensitivity to the HIF2α blockade by facilitating LDHA phosphorylation. Cell Death and Disease. 15(1). 64–64. 29 indexed citations

Zou, Zhihao, Zhengrong Zhang, Huichan He, et al.. (2024). Evaluation of glucocorticoid-related genes reveals GPD1 as a therapeutic target and regulator of sphingosine 1-phosphate metabolism in CRPC. Cancer Letters. 605. 217286–217286. 5 indexed citations

Ye, Jian‐Heng, Yuanfa Feng, Zhiduan Cai, et al.. (2023). Metformin escape in prostate cancer by activating the PTGR1 transcriptional program through a novel super-enhancer. Signal Transduction and Targeted Therapy. 8(1). 303–303. 12 indexed citations

Lü, Jianming, Jiahong Chen, Zhuoyuan Lin, et al.. (2023). A prognostic signature consisting of N6-methyladenosine modified mRNAs demonstrates clinical potential in prediction of biochemical recurrence and guidance on precision therapy in prostate cancer. Translational Oncology. 33. 101670–101670. 7 indexed citations

Liang, Yingke, Hongwei Luo, Chuanfan Zhong, et al.. (2023). N6-methyladenosine modified lncRNAs signature for stratification of biochemical recurrence in prostate cancer. Human Genetics. 143(7). 857–874. 2 indexed citations

Liang, Yuxiang, Yingke Liang, Zhihao Zou, et al.. (2022). Tumor Suppressor Role and Clinical Significance of the FEV Gene in Prostate Cancer. Disease Markers. 2022. 1–14. 4 indexed citations

10.

Han, Zhaodong, Yuanfa Feng, Yulin Deng, et al.. (2022). Integrated analysis reveals prognostic value and progression-related role of AMIGO2 in prostate cancer. Translational Andrology and Urology. 11(7). 914–928. 7 indexed citations

11.

Liu, Ren, Yuanfa Feng, Yulin Deng, et al.. (2021). A HIF1α-GPD1 feedforward loop inhibits the progression of renal clear cell carcinoma via mitochondrial function and lipid metabolism. Journal of Experimental & Clinical Cancer Research. 40(1). 188–188. 37 indexed citations

12.

Ye, Jian‐Heng, Zhiduan Cai, Yong Luo, et al.. (2020). GPD1 Enhances the Anticancer Effects of Metformin by Synergistically Increasing Total Cellular Glycerol-3-Phosphate. Cancer Research. 80(11). 2150–2162. 51 indexed citations

13.

Cai, Zhiduan, Yulin Deng, Jian‐Heng Ye, et al.. (2020). <p>Aberrant Expression of Citrate Synthase is Linked to Disease Progression and Clinical Outcome in Prostate Cancer</p>. Cancer Management and Research. Volume 12. 6149–6163. 21 indexed citations

14.

Dong, Weimin, Yong Luo, Hui Zhang, et al.. (2020). <p>Carbon Nanospheres Exert Antitumor Effects Associated with Downregulation of 4E-BP1 Expression on Prostate Cancer</p>. International Journal of Nanomedicine. Volume 15. 5545–5559. 5 indexed citations

15.

Liang, Yingke, et al.. (2020). The Role of Apoptin in Chicken Anemia Virus Replication. Pathogens. 9(4). 294–294. 15 indexed citations

16.

Liu, Zezhen, Zhaodong Han, Yingke Liang, et al.. (2019). TRIB1 induces macrophages to M2 phenotype by inhibiting IKB-zeta in prostate cancer. Cellular Signalling. 59. 152–162. 25 indexed citations

17.

Wang, Wei, Xiao-Liang Lan, Zhao‐Chong Zeng, et al.. (2019). CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer. Molecular Cancer. 18(1). 91–91. 588 indexed citations breakdown →

18.

Lü, Jianming, Weimin Dong, Huichan He, et al.. (2018). Autophagy induced by overexpression of DCTPP1 promotes tumor progression and predicts poor clinical outcome in prostate cancer. International Journal of Biological Macromolecules. 118(Pt A). 599–609. 32 indexed citations

19.

Liang, Yingke, et al.. (2018). The structure of mammalian β‐mannosidase provides insight into β‐mannosidosis and nystagmus. FEBS Journal. 286(7). 1319–1331. 12 indexed citations

20.

Liang, Yingke, Yanqiong Zhang, Zhaodong Han, et al.. (2017). Decreased expression of TCF12 contributes to progression and predicts biochemical recurrence in patients with prostate cancer. Tumor Biology. 39(6). 3726131992–3726131992. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact